Journal
NATURE REVIEWS NEUROSCIENCE
Volume 14, Issue 1, Pages 38-48Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn3406
Keywords
-
Categories
Funding
- US National Institutes of Health [AG5131, AG18440, AG022074, NS044233]
- Swiss National Science Foundation [31003A_120653]
- Ecole Polytechnique Federale de Lausanne (European Research Council)
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, P01NS044233] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [P01AG022074, R01AG018440, P50AG005131, P01AG010435, R37AG018440] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Disorders characterized by alpha-synuclein (alpha-syn) accumulation, Lewy body formation and parkinsonism (and in some cases dementia) are collectively known as Lewy body diseases. The molecular mechanism (or mechanisms) through which a-syn abnormally accumulates and contributes to neurodegeneration in these disorders remains unknown. Here, we provide an overview of current knowledge and prevailing hypotheses regarding the conformational, oligomerization and aggregation states of alpha-syn and their role in regulating alpha-syn function in health and disease. Understanding the nature of the various alpha-syn structures, how they are formed and their relative contributions to alpha-syn-mediated toxicity may inform future studies aiming to develop therapeutic prevention and intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available